DHCNL — Stock Film
STOCK FILMSCENE 1/11DHCNL · $18.78
Stock Expert AI presents
DHCNL
Diversified Healthcare Trust
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Diversified Healthcare Trust. A quick introduction.

On the stock market since 2020, it operates in the world of real estate. It has 600 employees. Now — the numbers.

on the stock market since 2020
600 employees
$2.3B market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $1.2.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

WHERE DOES THE MONEY COME FROM?
85%Resident Fees and Services
Resident Fees and Services 85%Rental Income 15%
85% of all revenue comes from a single line: Resident Fees and Services.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

In the vault right now:
$0
DEBT: $2.4B
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
8
very weak

Clearly below the class average.

FINANCIAL STRENGTH
19
very weak

Clearly below the class average.

VALUATION
24
very weak

Clearly below the class average.

GROWTH
12
very weak

Clearly below the class average.

PRICE MOMENTUM
84
very strong

The stock has been running stronger than the market lately.

WORTH WATCHING

Business Quality: Profit power and business quality trail similar companies in the sector.

Growth: Sales growth trails the sector average.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
Heavy bets against the stock2/10
Thin profit on each sale3/10
WORTH WATCHING

Bets Against the Stock: The number of investors betting on a fall stands out.

THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 27% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/2
Sales are holding up

The company sells $1.5B a year; the problem isn’t sales — it’s costs running above that number.

2
THE BRIGHT SIDE · 2/2
Pays a steady dividend

It pays out $1.56 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/3
The losses continue

A loss of $285.9M against $1.5B in annual sales.

2
THE RISKS · 2/3
A wildly swinging price

This stock swings about 2.3 times as much as the market average. Big rallies — and big drops — can both happen fast.

3
THE RISKS · 3/3
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

FINALE · THE GRADE
F
0 / 100 · MoonshotScore

On our five-subject report card, DHCNL sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: DHCNL has solid sales but closed last year at a loss. The road back to profit runs through spending discipline.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film